Stock listing

KRX:006280 GC Biopharma Corp. (녹십자) 주가

Follow GC Biopharma Corp. into a list and get an email when it puts out news.

Share price · KRX:006280

₩127,400 KRW 0 (0.0%)

Close on Oct 14, 2026

GC Biopharma Corp. logo
Ticker
KRX:006280
Asset type
Stock
Exchange
KRX
Currency
KRW

What changed lately

Latest news

GC Biopharma's Hunter Syndrome Treatment 'Hunterase' Receives Drug Approval in India and Taiwan

Aug 24, 2026

GC Biopharma Announces Lunch Symposium and Poster Presentations on IVIG Product Characterization at the 2026 CIS Annual Meeting

May 4, 2026

GC Biopharma Announces Presentation on Aggregation Profiles of Commercial IVIG Products at NHIA 2026

Apr 16, 2026

GC Biopharma Enhances IVIG Safety Profile with Advanced Prothrombotic Impurity Detection Technology

Apr 6, 2026

GC Biopharma Receives Marketing Authorization for Varicella Vaccine 'BARYCELA Inj.' in Guatemala

Mar 26, 2026

GC Biopharma Publishes a Comprehensive Review Paper Summarizing 30 Years of Accumulated Data on Its Proprietary Varicella Vaccine Strain, 'MAV/06'

Mar 11, 2026

GC Biopharma Secures IND Approval for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea

Dec 22, 2025

GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.'

Dec 8, 2025

GC Biopharma's Varicella Vaccine Strain 'MAV/06' Listed in WHO Position Paper

Dec 2, 2025

GC Biopharma Supports New Insights into Education, Safety, and Patient Outcomes in Ig Therapy Care at the 2025 IgNS Annual Meeting

Nov 6, 2025

All GC Biopharma Corp. news

GC Biopharma Corp. on 6ix

News releases
11 in the last 12 months · 23 in all · newest Aug 24, 2026 · oldest 2025

Log in to ask 6ix AI your own questions about GC Biopharma Corp.